Article
Genetic Markers of Therapeutic Efficacy of Methotrexate in Patients with Psoriasis.
Bulletin of experimental biology and medicine - 1 Feb 2022
Voron'ko O E, Baskaev K K, Sobolev V V, Denisova E V, Korsunskaya I M
Abstract excerpt
We studied the effect of C677T and A1298C polymorphisms of the MTHFR gene and 2R/3R polymorphisms of the TYMS gene on the sensitivity to methotrexate in patients with psoriasis (n=139). It was shown that genotype 3R/3R TYMS (OR 8.86, 95%CI 2.00-39.22) and complex genotypes MTHFR1298:A;TYMS:3R (OR 8.20, 95%CI 2.36-28.48) and MTHFR677:C;TYMS:3R (OR 5.40, 95%CI 1.95-14.94) were associated with sensitivity to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
